CARTERRA KICKS OFF 2025 SYMPOSIA SERIES ON ADVANCING DRUG DISCOVERY

KUALA LUMPUR, April 28 (Bernama) -- Carterra Inc, a provider of innovative technologies, is partnering with ImmunoPrecise Antibodies (IPA), ACROBiosystems, and Curia to host its 2025 symposia series titled “Unlocking High-Throughput Biology in Drug Discovery”.

The series will feature four one-day events across key cities in the United States (US) and Europe, including Boston on May 6, Munich on June 4, Cambridge on June 6, and San Francisco on June 24.

“Past attendees of Carterra’s symposia have shared their enthusiasm, highlighting the wide variety of presentations as well as the collaborative, open environment as reasons to attend. We are looking forward to record attendance and premium content again this year,” said its Vice President of Marketing and Product, Chris Silva in a statement.

bootstrap slideshow

The symposia are tailored for the drug discovery scientist, with topics covering antibody and large molecule through small molecule discovery, including cutting-edge areas such as machine learning and artificial intelligence approaches for protein engineering, emerging oncology targets, engineering of bispecific and multifunctional antibodies.

Speakers for the events will include leading scientists from the Institute for Protein Innovation (IPI), Pfizer, GSK, ACROBiosystems, Bio-Techne, Curia, ImmunoPrecise Antibodies (IPA), Ordaos, The Pirbright Institute, University of Oxford, and University of Pennsylvania.

Carterra will also debut data from its newly launched Carterra Ultra platform, which was introduced in September last year.

The Ultra instrument provides a full complement of small and large molecule applications while reprising gold-standard SPR detection, high throughput, and the minimal sample requirements of Carterra’s LSA and LSAXT systems.

-- BERNAMA